Search

56 results for “Clinical trial”

• Open Access

  Naloxegol: First oral peripherally acting mu opioid receptor antagonists for opioid-induced constipation

  Tejus Anantharamu, Sushil Sharma, Ajay Kumar Gupta, Navdeep Dahiya, Dick B. Singh Brashier

  Vol. 6 · Issue 3 · pp. 188–192

  https://doi.org/10.4103/0976-500X.162015
  Full text ↗PDF

• Educational ForumOpen Access

  Off‑label use of medicine: Perspective of physicians, patients, pharmaceutical companies and regulatory authorities

  Sandeep Kumar Gupta, Roopa Prasad Nayak

  Vol. 5 · Issue 2 · pp. 88–92

  https://doi.org/10.4103/0976-500X.130046
  Full text ↗PDF

• Molecules of the MillenniumOpen Access

  Sofosbuvir: A novel treatment option for chronic hepatitis C infection

  Harmeet Kaur Bhatia, Harmanjit Singh, Nipunjot Grewal, Navreet Kaur Natt

  Vol. 5 · Issue 4 · pp. 278–284

  https://doi.org/10.4103/0976-500X.142464
  Full text ↗PDF

• Mini ReviewOpen Access

  Comparative evaluation of adverse drug reaction reporting forms for introduction of a spontaneous generic ADR form

  Anshi Singh, Parloop Bhatt

  Vol. 3 · Issue 3 · pp. 228–229

  https://doi.org/10.4103/0976-500X.99417
  Full text ↗PDF

• CorrespondenceOpen Access

  An adverse drug reaction clinic: Breathing fresh life into the pharmacovigilance programme

  Dick B. S. Brashier, Sushil Sharma

  Vol. 3 · Issue 1 · pp. 74–75

  https://doi.org/10.4103/0976-500X.92501
  Full text ↗PDF

• Molecules of the MillenniumOpen Access

  Asenapine, a new sublingual atypical antipsychotic

  Balaraman R, Hardik Gandhi

  Vol. 1 · Issue 1 · pp. 60–61

  https://doi.org/10.4103/0976-500X.64538
  Full text ↗PDF

• Review ArticleOpen Access

  Review on Exploring Role of Vitamin D on Alzheimer’s Disease: Mechanistic Insights and Implications

  Nagaraju Bandaru, Mohan Gandhi Bonthu, Alluri Pavani Gayatri, Shashikala Metri, Perli Kranti Kumar, Aneesha Addanki, Srilaksmi Nallapaty, Karri Swathi Priya, Dodda Tulase Nadhreddy, P. N. S. Gowravi

  Vol. 16 · Issue 2 · pp. 164–171

  https://doi.org/10.1177/0976500X241312726
  Full text ↗PDF

• Review ArticleOpen Access

  Clinical and economic burden of adverse drug reactions

  Janet Sultana, Paola Cutroneo, Gianluca Trifirò

  Vol. 4 · Issue 1 · pp. S73–S74

  https://doi.org/10.4103/0976-500X.120957
  Full text ↗PDF

• Molecules of the MillenniumOpen Access

  Macitentan: An important addition to the treatment of pulmonary arterial hypertension

  Anjan Khadka, Dick B Singh Brashier, Anantharamu Tejus, Ashok Kumar Sharma

  Vol. 6 · Issue 1 · pp. 53–57

  https://doi.org/10.4103/0976-500X.149151
  Full text ↗PDF

• Special ArticleOpen Access

  CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials

  Kenneth F. Schulz, Douglas G. Altman, David Moher

  Vol. 1 · Issue 2 · pp. 100–101

  https://doi.org/10.4103/0976-500X.72352
  Full text ↗PDF

• Research LetterOpen Access

  Penetration of Bromelain in Serum and Rhinosinusal Mucosa in Patients Undergoing Endoscopic Sinus Surgery

  Desiderio Passali, Luisa Maria Bellussi, Codrut Sarafoleanu, Michele Loglisci, Claudiu Manea, Cristina Iosif, Francesco Maria Passali

  Vol. 8 · Issue 3 · pp. 128–9

  https://doi.org/10.4103/jpp.JPP_169_16
  Full text ↗PDF

• CorrespondenceOpen Access

  Good! Is it the best???

  Sandhiya Selvarajan, Steven Aibor Dkhar, Ajith Ananthakrishna Pillai

  Vol. 4 · Issue 3 · pp. 220–221

  https://doi.org/10.4103/0976-500X.114611
  Full text ↗PDF

• EditorialOpen Access

  Are we moving towards a new definition of essential medicines?

  Manikandan S

  Vol. 6 · Issue 3 · pp. 123–5

  https://doi.org/10.4103/0976-500X.162008
  Full text ↗PDF

• Research PaperOpen Access

  Antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage: A randomized trial

  Ajit Agarwal, Sathasivam Suresh Kumar, Jagdish Sadasivan, Vikram Kate

  Vol. 5 · Issue 1 · pp. 83–87

  https://doi.org/10.4103/0976-500X.149139
  Full text ↗PDF

• Mini ReviewOpen Access

  Cabazitaxel: A novel taxane for metastatic castration‑resistant prostate cancer‑current implications and future prospects

  Afroz Abidi

  Vol. 4 · Issue 4 · pp. 230–237

  https://doi.org/10.4103/0976-500X.119704
  Full text ↗PDF

• CorrespondenceOpen Access

  Authors' reply

  George Melvin, Selvarajan Sandhiya, Kumaresan Subraja

  Vol. 3 · Issue 1 · pp. 83–84

  https://doi.org/10.4103/0976-500X.92510
  Full text ↗PDF